- Report
- October 2024
- 211 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- May 2025
- 110 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- May 2025
- 153 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- August 2025
- 150 Pages
Global
From €2963EUR$3,358USD£2,562GBP
€3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 150 Pages
Global
From €2888EUR$3,273USD£2,497GBP
€3397EUR$3,850USD£2,938GBP
- Report
- August 2025
- 150 Pages
Global
From €2963EUR$3,358USD£2,562GBP
€3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 150 Pages
Global
From €2963EUR$3,358USD£2,562GBP
€3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 150 Pages
Global
From €2963EUR$3,358USD£2,562GBP
€3485EUR$3,950USD£3,014GBP
- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- July 2025
- 350 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Report
- August 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
- Report
- April 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- April 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- March 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- March 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- February 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more